Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.39 USD | +2.92% | +0.68% | -37.87% |
Apr. 29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
Apr. 26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.87% | 2.21B | |
+41.01% | 2.68B | |
+21.65% | 527M | |
+42.77% | 467M | |
-59.99% | 157M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Chief Executive Leaves, Chief Financial Officer Mala Murthy Named Acting CEO